OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION
associated with 3451 other trademarks
Providing health information about pharmaceuticals containing monoclonal antibodies

Words that describe this trademark:

central nervous system  nervous system health  diseases disorders  system health  treatment diseases  pharmaceutical preparations  syringes  disorders  prefilled  preparations 

Serial Number:

90533968

Mark:

OMB KESIMPTA (OFATUMUMAB) 20 MG INJECTION

Status:

Registered

Status Date:

08-15-2023

Filing Date:

Registration Number:

7139722

Registration Date:

08-15-2023

Goods and Services:

Providing health information about pharmaceuticals containing monoclonal antibodies

Mark Description:

The mark consists of the stylized letters "OMB", displayed at a forty-five degree tilt, with the "O" in coral and the combined letters "MB" in teal, followed by the word "KESIMPTA" in a stylized brown font above the words "(ofatumumab) 20 mg injection" in a stylized brown font. The color white is not claimed and appears as background only.

Class:

Medical services

Type of Mark:

Servicemark

Published for Opposition Date:

10-19-2021

Mark Drawing Status:

Words, Letters, and/or Numbers in Stylized From

Abandon Date:

N/A

Business Name:

TEPPER & EYSTER, PLLC

Correspondent Name:

Recent Trademark filings by this company